Latest

The Edition

Get set for the Media-AI content wars

Market Wrap

ASX finishes edges lower for flat week, AUD below 64 US cents

Australia and Tuvalu sign treaty on migration, climate and security

Chinese stocks have taken a beating. Here is the case for a rebound.

Private Debt

InfraBuild prices $550m bond deal with hefty interest

Economists are torn on Jim Chalmers’ Productivity Commission overhaul

Ransomware Attack

Hackers target China's ICBC, US Treasury trades disrupted

Falk Walks

OAIC commissioner Angelene Falk won't seek third term

ASIC Crackdown

$17.4m in compensation paid to retail investors by OTC derivative issuers

Media Deals

Southern Cross confirms ACM merger proposal

A deep dive into UBS' plan to rid itself of Credit Suisse's Australian debt

Credit Rating

Australia keeps AAA-rating as Fitch sees hike cycle end

Tech Raising

Roller raises US$50m in round led by Insight Partners

The Australian scientists behind cancer-fighting biotech Cartherics

Media Pain

News Corp posts drop in first-quarter profit

Next Move

Nvidia to release new chips for China following US restrictions: Reuters

Fresh Raising

Community platform Lounge raises $4m in seed round

Property Pickup

Strong winter market helps REA Group's Q1 earnings

Weak Futures

Australian shares set to start lower after Wall Street decline

US Rates

Fed’s Powell spooks markets with hawkish comments

Women smashed the glass ceiling in economics. Now they're worried about what comes next

Business Rebound

Business turnover rebounds further in September: ABS

Retail Pressure

Myer shares slump 1.9% as update underwhelms

Terms and Conditions

New laws on contract terms take effect

The Edition

Power moves

Market Wrap

ASX ekes out modest gain, AUD buying US64.14 cents

A tale of two TV companies: Nine bullish on AI and regulation, Seven shares sink

China Woes

China slips back into deflationary territory as demand wanes

Rough Week / Update

Optus to face inquiry, review on outage amid calls for compensation

Number Crunching / Update

Xero shares sink 11.3% as results disappoint

VC Raise

Atlassian, Telstra Ventures back Israeli AI developer play

Drug Approval

US, UK regulators approve Eli Lilly weight-loss drug to rival Wegovy

Political Capital

Gritted teeth on broken promises

NAB's bland result is just what the doctor ordered

Auckland Airport mandates MUFG, Westpac for AUD bond issue

Rough Week

Optus half-year earnings slide 13.9%

Cautious Outlook

Fonterra milks FY23 earnings amid wary market forecast

Explosive Growth / Update

Orica shares rise on profit jump, lift in outlook

New Normal

Scentre approaches pre-Covid occupancy

Number Crunching

Xero drops despite switch to half-year profit